Ask AI
H.R. 916

Prescription Drug Prices Review Board Act of 1993

Prescription Drug Prices Review Board Act of 1993 - Establishes in the Food and Drug Administration the Patented Medicine Prices Review Board which shall have the power to decrease the length of term of a prescription drug patent if, after notice and a hearing, it is found that the drug's price is excessive. Defines the term excessive price. Allows the Board to require the recapture of tax benefits provided to the patentee of an excessively priced drug.

Sponsor introductory remarks on measure. (CR E1889)

Rep. Stark, Fortney Pete [D-CA-13](D-CA)Sponsor
34 cosponsors34 D1 I
34cosponsors3committees20actions17subjects
  1. IntroReferralB00100

    Sponsor introductory remarks on measure. (CR E1889)

  2. CommitteeH11000

    Referred to the Subcommittee on Intellectual Property and Judicial Administration.

    Courts, Intellectual Property, Artificial Intelligence, and the Internet Subcommittee
  3. IntroReferralB00100

    Sponsor introductory remarks on measure. (CR E1745-1746)

  4. IntroReferralB00100

    Sponsor introductory remarks on measure. (CR E1598)

  5. IntroReferralB00100

    Sponsor introductory remarks on measure. (CR E1539)

  6. IntroReferralB00100

    Sponsor introductory remarks on measure. (CR E1532-1533)

  7. IntroReferralB00100

    Sponsor introductory remarks on measure. (CR E1486)

  8. IntroReferralB00100

    Sponsor introductory remarks on measure. (CR E1419-1420)

  9. IntroReferralB00100

    Sponsor introductory remarks on measure. (CR E1346)

  10. IntroReferralB00100

    Sponsor introductory remarks on measure. (CR E1273)

  11. IntroReferralB00100

    Sponsor introductory remarks on measure. (CR H2486)

  12. IntroReferralB00100

    Sponsor introductory remarks on measure. (CR E1152-1153)

  13. IntroReferralB00100

    Sponsor introductory remarks on measure. (CR E760)

  14. CommitteeH11000

    Referred to the Subcommittee on Health and the Environment.

    Health and Environment Subcommittee
  15. IntroReferralB00100

    Sponsor introductory remarks on measure. (CR H658-659)

  16. IntroReferralH11100

    Referred to the House Committee on Ways and Means.

    Ways and Means Committee
  17. IntroReferralH11100

    Referred to the House Committee on Judiciary.

    Judiciary Committee
  18. IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  19. IntroReferralIntro-H

    Introduced in House

  20. IntroReferral1000

    Introduced in House